Drug Use Investigation of Gadovist
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Gadobutrol (Primary)
- Indications Breast cancer; Vascular disorders
- Focus Adverse reactions
- Sponsors Bayer
- 26 Sep 2017 Planned primary completion date changed from 15 Sep 2017 to 15 Sep 2018.
- 27 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 Sep 2015 Planned initiation date changed from 1 Sep 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.